Lipids in Pulmonary Drug Delivery
Editat de Md Faiyazuddin, Hasan Ali, MD Akbar, Babar Iqbalen Limba Engleză Paperback – feb 2025
- Presents unique and comprehensive information on lipid-based nanomedicines for pulmonary drug delivery
- Provides insights into the biological fate and interplay of nanoparticles with the environment of the pulmonary system
- Acts as a guide for the future applications of lipid-based nanomedicine in the clinical setting for the precise management of pulmonary diseases
Preț: 860.20 lei
Preț vechi: 1083.77 lei
-21% Nou
Puncte Express: 1290
Preț estimativ în valută:
164.62€ • 173.17$ • 137.36£
164.62€ • 173.17$ • 137.36£
Carte nepublicată încă
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443223747
ISBN-10: 0443223742
Pagini: 400
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
ISBN-10: 0443223742
Pagini: 400
Dimensiuni: 191 x 235 mm
Editura: ELSEVIER SCIENCE
Cuprins
1. Lipid Nanotechnology
2. Current Scenario and Challenges of Lipid-Based Nanomedicines for Pulmonary Drug Delivery
3. Effect of Environment of the Respiratory Tract on Nanomedicine Drug Delivery
4. Aerodynamics and Deposition of Lipid Based Nanocarriers in Lungs
5. Liposome as a Versatile Carrier for Pulmonary Drug Delivery
6. Advancements in Nano-Structured Lipid Carrier (NlCs) as Drug Delivery Vehicle in Lungs
7. Solid Lipid Nanoparticles: A Potential Drug Carrier in Pulmonary System
8. Insights and Applications of Nanoemulsions as a Drug Carrier in Lungs
9. Lipid Based Drug Delivery for Lungs Cancer
10. Lipid Nanomedicine for Obstructive Pulmonary Disease
11. Lipid Based Drug Delivery for Pulmonary Microbial Infections
12. Lipid-Based Drug Delivery for Systemic Effect Through Pulmonary Route of Administration
13. Biofate of Lipid-Based Nanomedicine after Pulmonary Administration
14. Surface Modification of Lipid-Based Drug Delivery for Lungs
15. Evaluation of Lipid-Based Formulation for Pulmonary Delivery
16. Physico-Chemical Stability of Lipid-Based Nanocarriers in Aerosol Formulation
17. Translation of Lipid-Based Formulation for Pulmonary DDS: Clinical Status
18. Regulatory Aspects of Lipid-Based Nanomedicine for Pulmonary Applications
2. Current Scenario and Challenges of Lipid-Based Nanomedicines for Pulmonary Drug Delivery
3. Effect of Environment of the Respiratory Tract on Nanomedicine Drug Delivery
4. Aerodynamics and Deposition of Lipid Based Nanocarriers in Lungs
5. Liposome as a Versatile Carrier for Pulmonary Drug Delivery
6. Advancements in Nano-Structured Lipid Carrier (NlCs) as Drug Delivery Vehicle in Lungs
7. Solid Lipid Nanoparticles: A Potential Drug Carrier in Pulmonary System
8. Insights and Applications of Nanoemulsions as a Drug Carrier in Lungs
9. Lipid Based Drug Delivery for Lungs Cancer
10. Lipid Nanomedicine for Obstructive Pulmonary Disease
11. Lipid Based Drug Delivery for Pulmonary Microbial Infections
12. Lipid-Based Drug Delivery for Systemic Effect Through Pulmonary Route of Administration
13. Biofate of Lipid-Based Nanomedicine after Pulmonary Administration
14. Surface Modification of Lipid-Based Drug Delivery for Lungs
15. Evaluation of Lipid-Based Formulation for Pulmonary Delivery
16. Physico-Chemical Stability of Lipid-Based Nanocarriers in Aerosol Formulation
17. Translation of Lipid-Based Formulation for Pulmonary DDS: Clinical Status
18. Regulatory Aspects of Lipid-Based Nanomedicine for Pulmonary Applications